Qing-Xiang Amy Sang Selected Research

Matrix Metalloproteinase 7 (Matrilysin)

1/2013	The Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer Cells.
3/2011	Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA.
1/2010	Effects of detergents on catalytic activity of human endometase/matrilysin 2, a putative cancer biomarker.
4/2007	Calcium regulates tertiary structure and enzymatic activity of human endometase/matrilysin-2 and its role in promoting human breast cancer cell invasion.
1/2004	Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
4/2003	Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells.
9/2002	Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing-Xiang Amy Sang Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 07/2002
19	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2003
16	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2004
9	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2010
7	Carcinoma (Carcinomatosis) 01/2013 - 04/2003
6	Inflammation (Inflammations) 01/2022 - 01/2010
3	Disease Progression 01/2021 - 01/2016
3	Stroke (Strokes) 01/2017 - 01/2006
3	Obesity 01/2017 - 01/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2006
2	Alzheimer Disease (Alzheimer's Disease) 11/2011 - 01/2009
2	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2011 - 01/2004
2	Carcinogenesis 01/2011 - 12/2005
2	Prostatitis 06/2010 - 04/2003
2	Hyperplasia 01/2004 - 04/2003
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Adenocarcinoma 06/2020
1	Medulloblastoma 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Symptom Flare Up 01/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Phototoxic Dermatitis (Phototoxicity) 01/2017
1	Atopic Dermatitis (Atopic Eczema) 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016
1	Insulin Resistance 01/2013
1	Wounds and Injuries (Trauma) 02/2012

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 06/2020 - 07/2002
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2005
10	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2004
9	Pharmaceutical PreparationsIBA 01/2018 - 01/2006
8	AndrogensIBA 01/2021 - 04/2003
7	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2013 - 09/2002
5	EnzymesIBA 01/2013 - 07/2002
4	RNA (Ribonucleic Acid)IBA 01/2021 - 07/2017
4	Estrogen ReceptorsIBA 01/2012 - 12/2004
3	Matrix Metalloproteinase InhibitorsIBA 01/2017 - 12/2004
3	Complementary DNA (cDNA)IBA 01/2016 - 04/2007
3	Amyloid (Amyloid Fibrils)IBA 01/2016 - 01/2009
2	Granzymes (Granzyme)IBA 01/2021 - 01/2020
2	Cadherins (E-Cadherin)IBA 01/2021 - 09/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 01/2015
2	Messenger RNA (mRNA)IBA 07/2017 - 01/2004
2	ResistinIBA 01/2016 - 01/2013
2	Biological ProductsIBA 01/2016 - 02/2007
2	LigandsIBA 01/2016 - 09/2007
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2011 - 01/2009
2	Peptide Hydrolases (Proteases)FDA Link 06/2010 - 12/2004
2	Fibronectins (Fibronectin)IBA 11/2009 - 12/2005
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2004 - 04/2003
1	ferric oxide (iron oxide)IBA 01/2022
1	IronIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	OxidesIBA 01/2022
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021
1	sphingosine kinaseIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	VimentinIBA 01/2021
1	VaccinesIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 06/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2020
1	ProteomeIBA 07/2017
1	beta CateninIBA 07/2017
1	Caveolin 1IBA 07/2017
1	Minichromosome Maintenance Complex Component 3IBA 06/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	CytokinesIBA 01/2017
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	AgrinIBA 01/2016
1	Aldehyde DehydrogenaseIBA 01/2016
1	Cytoskeletal ProteinsIBA 01/2016
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2016
1	Extracellular Matrix ProteinsIBA 01/2016
1	Fatty Acid-Binding ProteinsIBA 01/2016
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	EndopeptidasesIBA 01/2013
1	Biological FactorsIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Long Noncoding RNAIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	SERPIN-B5 (maspin)IBA 09/2012
1	MicroRNAs (MicroRNA)IBA 09/2012

Therapy/Procedure

7	Therapeutics 01/2021 - 08/2009
3	Immunotherapy 01/2021 - 01/2018
2	Lasers (Laser) 06/2010 - 01/2004
1	Castration 01/2021
1	Precision Medicine 01/2018
1	Subcutaneous Injections 06/2017
1	Drug Therapy (Chemotherapy) 01/2017